Cafepharma Today

May 21 2025 - Medtronic plans to separate its diabetes business into a new company
Medtronic plans to separate its diabetes business into a new company
Moderna shares down after pulling Covid-flu combo vaccine application
Roche's Genentech sticks with Orionis in 2nd molecular glue deal worth $2B
RFK Jr. takes fire in Senate hearing on research cuts
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Focus On Transcept As Intermezzo's Fate Awaits FDA
Seeking Alpha
Tuesday, November 22, 2011 - 9:36am
tags:
Transcept, Intermezzo, FDA, insomnia
Pfizer to buy Excaliard Pharma for skin drug
Yahoo/Reuters
Tuesday, November 22, 2011 - 9:34am
tags:
Pfizer, Excaliard, M&A, EXC 001
Hidden Gems In Pfizer's Annual Report May Reveal The Holy Grail Of Pharmaceuticals
Seeking Alpha
Monday, November 21, 2011 - 6:34pm
tags:
Pfizer, Teva Pharmaceuticals, dividends
Amylin's Agreement with Lilly Will Not Lead It To Profitablity
Seeking Alpha
Monday, November 21, 2011 - 6:29pm
tags:
Eli Lilly, Amylin, GSK, Merck, Alkermes, Byetta, Novo Nordisk
This Biotech Has Almost Everything Going for It
Motley Fool
Monday, November 21, 2011 - 6:28pm
tags:
Eyelea, Regeneron
Why Congress’ Failure Could be a Good Thing for Pharma, Hospitals
Barron's
Monday, November 21, 2011 - 6:27pm
tags:
congress, pharma industry, deficit
Pfizer To Pay $60M To Settle Bribery Probe
Pharmalot
Monday, November 21, 2011 - 1:10pm
tags:
Pfizer, bribery, settlements
A Step Forward for RNA Interference
NY Times, NY
Monday, November 21, 2011 - 1:02pm
tags:
Alnylam, RNA interference, RNAi
Bayer emails discuss off-label uses for Yaz, Yasmin
Fierce Pharma
Monday, November 21, 2011 - 1:00pm
tags:
off-label, Bayer, Yaz, Yasmin, birth control pill
Regeneron up 10% on FDA approval
Marketwatch
Monday, November 21, 2011 - 12:59pm
tags:
Regeneron, FDA, Eyelea
Why the Street Should Expect Big Things From Merck
Motley Fool
Monday, November 21, 2011 - 12:55pm
tags:
Merck
Dendreon: Medicare will cover more Provenge costs
Yahoo/AP
Monday, November 21, 2011 - 11:43am
tags:
Dendreon, Medicare, Provenge, prostate cancer
Impax Sued by Teva’s Cephalon Over Fentora Pain Drug Patents
Bloomberg
Monday, November 21, 2011 - 11:39am
tags:
Impax, Teva Pharmaceuticals, Cephalon, Fentroa, cancer pain
Troubled Boehringer Unit Suspends Manufacturing
Pharmalot
Monday, November 21, 2011 - 11:37am
tags:
Ben Venue, Boehringer Ingelheim
Gilead to Buy Pharmasset for $11B for Hepatitis C Treatments
Bloomberg
Monday, November 21, 2011 - 9:44am
tags:
Gilead, Pharmasset, hepatitis C
Mylan to sell generic version of Vivelle-Dot
Bizjournals.com
Monday, November 21, 2011 - 9:42am
tags:
Mylan, generics, Vivelle-Dot, menopause, estrogen patch, Novartis
Four former Synthes execs could get prison terms
Bizjournals.com
Monday, November 21, 2011 - 9:39am
tags:
Synthes, Norian, JNJ
Orchid to supply antibiotic drug to Hospira
Business Standard, India
Sunday, November 20, 2011 - 12:25pm
tags:
Orchid Pharma, imipenem-cilastatin, generics, Hospira
Biotech Focused Hedge Fund RA Capital's Top Q3 Picks
Seeking Alpha
Sunday, November 20, 2011 - 12:21pm
tags:
Columbia Laboratories, Sequenom, Raptor Pharmaceuticals
GSK investors told of crucial new drugs on the way
The Independent, UK
Sunday, November 20, 2011 - 12:20pm
tags:
GSK, open-access R&D

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.